1. Home
  2. REVB vs YCBD Comparison

REVB vs YCBD Comparison

Compare REVB & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.15

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo cbdMD Inc.

YCBD

cbdMD Inc.

HOLD

Current Price

$0.64

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
YCBD
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REVB
YCBD
Price
$1.15
$0.64
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
107.2K
999.4K
Earning Date
11-06-2025
12-15-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,026,064.00
Revenue This Year
N/A
$0.37
Revenue Next Year
N/A
$4.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$0.47
52 Week High
$60.48
$6.54

Technical Indicators

Market Signals
Indicator
REVB
YCBD
Relative Strength Index (RSI) 63.48 43.40
Support Level $1.03 $0.60
Resistance Level $1.00 $0.67
Average True Range (ATR) 0.08 0.08
MACD 0.04 0.02
Stochastic Oscillator 93.03 38.11

Price Performance

Historical Comparison
REVB
YCBD

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: